Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 2
1996 1
1998 1
1999 1
2000 3
2001 10
2002 8
2003 5
2004 11
2005 8
2006 11
2007 3
2008 5
2009 5
2010 5
2011 5
2012 6
2013 11
2014 14
2015 17
2016 4
2017 7
2018 5
2019 6
2020 5
2021 5
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

154 results
Results by year
Filters applied: . Clear all
Page 1
Flow cytometry in analysis of cell cycle and apoptosis.
Darzynkiewicz Z, Bedner E, Smolewski P. Darzynkiewicz Z, et al. Among authors: smolewski p. Semin Hematol. 2001 Apr;38(2):179-93. doi: 10.1016/s0037-1963(01)90051-4. Semin Hematol. 2001. PMID: 11309699 Review.
Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin's Lymphoma.
Connors JM, Jurczak W, Straus DJ, Ansell SM, Kim WS, Gallamini A, Younes A, Alekseev S, Illés Á, Picardi M, Lech-Maranda E, Oki Y, Feldman T, Smolewski P, Savage KJ, Bartlett NL, Walewski J, Chen R, Ramchandren R, Zinzani PL, Cunningham D, Rosta A, Josephson NC, Song E, Sachs J, Liu R, Jolin HA, Huebner D, Radford J; ECHELON-1 Study Group. Connors JM, et al. Among authors: smolewski p. N Engl J Med. 2018 Jan 25;378(4):331-344. doi: 10.1056/NEJMoa1708984. Epub 2017 Dec 10. N Engl J Med. 2018. PMID: 29224502 Free PMC article. Clinical Trial.
Brentuximab vedotin with chemotherapy for stage III/IV classical Hodgkin lymphoma: 3-year update of the ECHELON-1 study.
Straus DJ, Długosz-Danecka M, Alekseev S, Illés Á, Picardi M, Lech-Maranda E, Feldman T, Smolewski P, Savage KJ, Bartlett NL, Walewski J, Ramchandren R, Zinzani PL, Hutchings M, Connors JM, Radford J, Munoz J, Kim WS, Advani R, Ansell SM, Younes A, Miao H, Liu R, Fenton K, Forero-Torres A, Gallamini A. Straus DJ, et al. Among authors: smolewski p. Blood. 2020 Mar 5;135(10):735-742. doi: 10.1182/blood.2019003127. Blood. 2020. PMID: 31945149 Free article. Clinical Trial.
Brentuximab vedotin with chemotherapy for stage III or IV classical Hodgkin lymphoma (ECHELON-1): 5-year update of an international, open-label, randomised, phase 3 trial.
Straus DJ, Długosz-Danecka M, Connors JM, Alekseev S, Illés Á, Picardi M, Lech-Maranda E, Feldman T, Smolewski P, Savage KJ, Bartlett NL, Walewski J, Ramchandren R, Zinzani PL, Hutchings M, Munoz J, Lee HJ, Kim WS, Advani R, Ansell SM, Younes A, Gallamini A, Liu R, Little M, Fenton K, Fanale M, Radford J. Straus DJ, et al. Among authors: smolewski p. Lancet Haematol. 2021 Jun;8(6):e410-e421. doi: 10.1016/S2352-3026(21)00102-2. Lancet Haematol. 2021. PMID: 34048680 Clinical Trial.
Immune Checkpoint Inhibitors to Treat Malignant Lymphomas.
Witkowska M, Smolewski P. Witkowska M, et al. Among authors: smolewski p. J Immunol Res. 2018 Apr 11;2018:1982423. doi: 10.1155/2018/1982423. eCollection 2018. J Immunol Res. 2018. PMID: 29850620 Free PMC article. Review.
Emerging antibody-drug conjugates for treating lymphoid malignancies.
Wolska-Washer A, Robak P, Smolewski P, Robak T. Wolska-Washer A, et al. Among authors: smolewski p. Expert Opin Emerg Drugs. 2017 Sep;22(3):259-273. doi: 10.1080/14728214.2017.1366447. Epub 2017 Aug 28. Expert Opin Emerg Drugs. 2017. PMID: 28792782 Review.
Treatment options for mantle cell lymphoma.
Smolewski P, Witkowska M, Robak T. Smolewski P, et al. Expert Opin Pharmacother. 2015;16(16):2497-507. doi: 10.1517/14656566.2015.1087507. Epub 2015 Sep 11. Expert Opin Pharmacother. 2015. PMID: 26360791 Review.
154 results